Pharsight

Jazz patents expiration

1. Sunosi patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9604917 JAZZ Treatment of sleep-wake disorders
Jun, 2026

(2 years from now)

US8877806 JAZZ Treatment of sleep-wake disorders
Jun, 2026

(2 years from now)

US10351517 JAZZ Treatment of sleep-wake disorders
Jun, 2026

(2 years from now)

US8440715 JAZZ Treatment of sleep-wake disorders
Jun, 2031

(7 years from now)

US10512609 JAZZ Formulations of (R)-2-amino-3-phenylpropyl carbamate
Sep, 2037

(13 years from now)

US10195151 JAZZ Formulations of (R)-2-amino-3-phenylpropyl carbamate
Sep, 2037

(13 years from now)

US10912754 JAZZ Methods and compositions for treating excessive sleepiness
Jun, 2038

(14 years from now)

US10959976 JAZZ Methods and compositions for treating excessive sleepiness
Jun, 2038

(14 years from now)

US10940133 JAZZ Methods of providing solriamfetol therapy to subjects with impaired renal function
Mar, 2040

(16 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Jun 17, 2024
Orphan Drug Exclusivity (ODE) Jun 17, 2026

Drugs and Companies using SOLRIAMFETOL HYDROCHLORIDE ingredient

NCE-1 date: 2023-06-18

Market Authorisation Date: 17 June, 2019

Treatment: To improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (osa); Treatment of excessive daytime sleepiness associated with obstru...

Dosage: TABLET;ORAL

How can I launch a generic of SUNOSI before it's drug patent expiration?
More Information on Dosage

SUNOSI family patents

Family Patents

2. Xywav patents expiration

XYWAV's oppositions filed in EPO
XYWAV Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8731963 JAZZ Sensitive drug distribution system and method
Dec, 2022

(1 year, 2 months ago)

US8731963

(Pediatric)

JAZZ Sensitive drug distribution system and method
Jun, 2023

(8 months ago)

US8591922 JAZZ Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
Jan, 2033

(8 years from now)

US11554102 JAZZ NA
Jan, 2033

(8 years from now)

US10195168 JAZZ Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
Jan, 2033

(8 years from now)

US8901173 JAZZ Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
Jan, 2033

(8 years from now)

US10675258 JAZZ Method of using gamma-hydroxybutyrate compositions for the treatment of disorders
Jan, 2033

(8 years from now)

US9132107 JAZZ Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
Jan, 2033

(8 years from now)

US9486426 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(9 years from now)

US8772306 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(9 years from now)

US9050302 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(9 years from now)

US10213400 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(9 years from now)

US10864181 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(9 years from now)

US11253494 JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Mar, 2033

(9 years from now)

US11253494

(Pediatric)

JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US10864181

(Pediatric)

JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US8772306

(Pediatric)

JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US9486426

(Pediatric)

JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US10213400

(Pediatric)

JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US9050302

(Pediatric)

JAZZ Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
Sep, 2033

(9 years from now)

US11426373 JAZZ Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
Sep, 2037

(13 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Aug 12, 2028
New Indication (I) Aug 12, 2024

Drugs and Companies using CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE ingredient

Market Authorisation Date: 21 July, 2020

Treatment: Method of treating a patient with a prescription drug using a computer database in a computer system for distribution; Treatment of cataplexy or excessive daytime sleepiness (eds) in patients 7 years ...

Dosage: SOLUTION;ORAL

How can I launch a generic of XYWAV before it's drug patent expiration?
More Information on Dosage

XYWAV family patents

Family Patents

3. Zepzelca patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7763615 JAZZ Ecteinascidin analogs for use as antitumour agents
Dec, 2029

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Jun 15, 2025
Orphan Drug Exclusivity (ODE) Jun 15, 2027

Drugs and Companies using LURBINECTEDIN ingredient

NCE-1 date: 2024-06-15

Market Authorisation Date: 15 June, 2020

Treatment: Treatment of adult patients with small cell lung cancer (sclc) with disease progression on or after platinum-based chemotherapy.

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

ZEPZELCA family patents

Family Patents